<DOC>
	<DOCNO>NCT02504801</DOCNO>
	<brief_summary>To test hypothesis nebulized Pulmicort Respules could reduce post operation pulmonary complication incidence primary lung cancer patient COPD . Compare post-operation pulmonary complication incidence two treatment arm among primary lung cancer patient COPD require single lobectomy 3days operation 7 day operation .</brief_summary>
	<brief_title>Efficacy Nebulized Pulmicort Respules Primary Lung Cancer Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>1 . Newly diagnose exist COPD define GOLD , FEV1 &lt; 80 % predict FEV1/FVC &lt; 70 % 2 . Diagnosed primary lung cancer China guideline diagnosis treatment primary lung cancer 3 . .Consistent indication operation pulmonary single lobectomy surgery China guideline diagnosis treatment primary lung cancer 4 . General anesthesia double cavity intubation use operation 5 . ASA Classification Anesthesia Risk category 13 baseline 6. age 4080 year old 7 . Smoking cessation two week operation 8 . SP O2 &gt; 90 % surgery 9 . Hemoglobin &gt; 10g/dl 10 . Estimated duration surgery &lt; 4 hour 11 . 18.5 &lt; BMI &lt; 28 1 . Patients take systemic corticosteroid precede 1month baseline 2 . Patients pneumonia precede 1month baseline 3 . Patients history recent myocardial infarction , heart failure , tuberculosis 4 . Subject know suspected human immunodeficiency virus infection</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>primary lung cancer patient</keyword>
</DOC>